{
  "id": "c151acff595a1153",
  "title": "Opna Bio Announces Orphan Drug Designation Granted to OPN - 2853 ( Zavabresib ) for the Treatment of Mye",
  "description": "20260121T190000Z",
  "content": "",
  "source": "pharmiweb.com",
  "source_url": "https://www.pharmiweb.com/press-release/2026-01-21/opna-bio-announces-orphan-drug-designation-granted-to-opn-2853-zavabresib-for-the-treatment-of-mye",
  "published_at": "20260121T190000Z",
  "fetched_at": "2026-01-22T00:25:11.997161+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmiweb.com/press-release/2026-01-21/opna-bio-announces-orphan-drug-designation-granted-to-opn-2853-zavabresib-for-the-treatment-of-mye",
    "url_mobile": "",
    "title": "Opna Bio Announces Orphan Drug Designation Granted to OPN - 2853 ( Zavabresib ) for the Treatment of Mye",
    "seendate": "20260121T190000Z",
    "socialimage": "https://cdn.pharmiweb.com/media/1024/1200x448-pwjobs.png",
    "domain": "pharmiweb.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}